Use of two medicated mouthwashes reduced pain from oral mucositis during the first four hours after administration; however, the results were not deemed clinically different when compared with placebo.
In this Special Edition of CURE Talks Cancer, we chat with Poison drummer and throat cancer survivor Rikki Rockett about his cancer journey and why it's important to "Open Up and Say... Ahh!" during Oral, Head and Neck Cancer Awareness Week.
The Food and Drug Administration granted a priority review to the supplemental biologics license application for Keytruda (pembrolizumab) for the first-line treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).